Cited by 117

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

p38α blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1α- to FoxO-dependent transcription

Chiacchiera, F, Matrone, A, Ferrari, E, Ingravallo, G, Lo Sasso, G, Murzilli, S, Petruzzelli, M, Salvatore, L, Moschetta, A, Simone, C·2009·Cell Death & Differentiation

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cdd.2009.36

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics. CA Cancer J Clin 2005; 55: 10–30. · DOI · Paper page
  2. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108–1113. · DOI · Paper page
  3. Rustgi AK . The genetics of hereditary colon cancer. Genes Dev 2007; 21: 2525–2538. · DOI
  4. Gatenby RA, Gillies RJ . Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4: 891–899. · DOI · Paper page
  5. Kroemer G, Pouyssegur J . Tumor cell metabolism: cancer's Achilles’ heel. Cancer Cell 2008; 13: 472–482. · DOI · Paper page
  6. Minet E, Michel G, Mottet D, Raes M, Michiels C . Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic Biol Med 2001; 31: 847–855. · DOI
  7. Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, Kenner L et al. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 2007; 39: 741–749. · DOI
  8. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL . p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004; 36: 738–743. · DOI
  9. Chiacchiera F, Simone C . Signal-dependent regulation of gene expression as a target for cancer treatment: inhibiting p38alpha in colorectal tumors. Cancer Lett 2008; 265: 16–26. · DOI
  10. Perdiguero E, Ruiz-Bonilla V, Serrano AL, Muñoz-Cánoves P . Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: the p38alpha-JNK connection. Cell Cycle 2007; 6: 1298–1303. · DOI
  11. Jacquet S, Zarrinpashneh E, Chavey A, Ginion A, Leclerc I, Viollet B et al. The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia. Cardiovasc Res 2007; 76: 465–472. · DOI
  12. Serra C, Palacios D, Mozzetta C, Forcales SV, Morantte I, Ripani M et al. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell 2007; 28: 200–213. · DOI
  13. Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M et al. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 2007; 39: 750–758. · DOI
  14. Kuwamura H, Tominaga K, Shiota M, Ashida R, Nakao T, Sasaki E et al. Growth inhibition of colon cancer cells by transfection of dominant-negative apoptosis signal-regulating kinase-1. Oncol Rep 2007; 17: 781–786.
  15. Gout S, Morin C, Haule F, Huot J . Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 2006; 66: 9117–9124. · DOI
  16. Comes F, Matrone A, Lastella P, Nico B, Susca FC, Bagnulo R et al. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ 2007; 14: 693–702. · DOI
  17. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4: 151–175. · DOI · Paper page
  18. Simone C . Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy 2007; 3: 468–471. · DOI
  19. Wang S, Mintz A, Mochizuki K, Dorsey JF, Ackermann JM, Alavi A et al. Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts. Cancer Biol Ther 2007; 6: 1649–1653. · DOI
  20. Karanam S, Moreno CS . CONFAC: automated application of comparative genomic promoter analysis to DNA microarray datasets. Nucleic Acids Res 2004; 32 (Web Server issue): W475–W484. · DOI
  21. Ho KK, Myatt SS, Lam EW . Many forks in the path: cycling with FoxO. Oncogene 2008; 27: 2300–2311. · DOI
  22. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007; 6: 458–471. · DOI · Paper page
  23. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6: 472–483. · DOI · Paper page
  24. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 2007; 282: 30107–30119. · DOI
  25. Emerling BM, Platanias LC, Black E, Nebreda AR, Davis RJ, Chandel NS . Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol 2005; 25: 4853–4862. · DOI
  26. Kwon SJ, Song JJ, Lee YJ . Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells. Clin Cancer Res 2005; 11: 7607–7613. · DOI
  27. Paulsen JE, Steffensen IL, Løberg EM, Husøy T, Namork E, Alexander J . Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res 2001; 61: 5010–5015.
  28. Suzui M, Okuno M, Tanaka T, Nakagama H, Moriwaki H . Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. Cancer Lett 2002; 183: 31–41. · DOI
  29. Issa AY, Volate SR, Muga SJ, Nitcheva D, Smith T, Wargovich MJ . Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model. Carcinogenesis 2007; 28: 1978–1984. · DOI
  30. White E . Autophagic cell death unraveled: Pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy 2008; 4: 399–401. · DOI
  31. Fantin VR, St-Pierre J, Leder P . Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006; 9: 425–434. · DOI · Paper page
  32. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454–5468. · DOI
  33. Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB, Pierce W et al. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 2001; 276: 3517–3523. · DOI
  34. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 2001; 276: 35243–35246. · DOI
  35. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B . JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 2008; 30: 678–688. · DOI · Paper page
  36. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304: 1500–1502. · DOI
  37. Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MT, Codogno P et al. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem 2006; 281: 34870–34879. · DOI · Paper page
  38. Gambhir SS . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683–693. · DOI
  39. Lee MR, Dominguez C . MAP kinase p38 Inhibitors: clinical results and an intimate look at their interactions with p38 protein. Curr Med Chem 2005; 12: 2979–2994. · DOI

Cited by

Sorted by citations

See all 117

Metadata

Authors
Chiacchiera, F., Matrone, A., Ferrari, E., Ingravallo, G., Lo Sasso, G., Murzilli, S., Petruzzelli, M., Salvatore, L., Moschetta, A., & Simone, C.
Venue
Cell Death & Differentiation
Published
2009-04-03
Volume
16
Issue
9
Pages
1203-1214
ISSN
  • 1350-9047
  • 1476-5403
Cited by
117
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review